| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 54766-772-45 | 54766-772 | HUMAN PRESCRIPTION DRUG | Naftin | Naftifine Hydrochloride | GEL | TOPICAL | 20180301 | 20261031 | NDA | NDA204286 | Sebela Pharmaceuticals Inc. | NAFTIFINE HYDROCHLORIDE | 2 g/100g | 1 TUBE in 1 CARTON (54766-772-45) / 45 g in 1 TUBE |
| 54766-772-60 | 54766-772 | HUMAN PRESCRIPTION DRUG | Naftin | Naftifine Hydrochloride | GEL | TOPICAL | 20180301 | 20261031 | NDA | NDA204286 | Sebela Pharmaceuticals Inc. | NAFTIFINE HYDROCHLORIDE | 2 g/100g | 1 TUBE in 1 CARTON (54766-772-60) / 60 g in 1 TUBE |
| 83107-023-45 | 83107-023 | HUMAN PRESCRIPTION DRUG | Naftin | Naftifine Hydrochloride | GEL | TOPICAL | 20250729 | N/A | NDA | NDA204286 | Legacy Pharma USA Inc. | NAFTIFINE HYDROCHLORIDE | 2 g/100g | 1 TUBE in 1 CARTON (83107-023-45) / 45 g in 1 TUBE |
| 83107-023-60 | 83107-023 | HUMAN PRESCRIPTION DRUG | Naftin | Naftifine Hydrochloride | GEL | TOPICAL | 20250729 | N/A | NDA | NDA204286 | Legacy Pharma USA Inc. | NAFTIFINE HYDROCHLORIDE | 2 g/100g | 1 TUBE in 1 CARTON (83107-023-60) / 60 g in 1 TUBE |